[HTML] nature.com

[HTML][HTML] Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson… - British journal of …, 2010 - nature.com
Background: The purpose of this work was to determine the efficacy of inhibiting mammalian
target of rapamycin (mTOR) in pancreatic cancer preclinical models and translate preclinical …
被引用次数：88 相关文章

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson… - British journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Background The purpose of this work was to determine the efficacy of inhibiting mammalian
target of rapamycin (mTOR) in pancreatic cancer preclinical models and translate preclinical …
[PDF] psu.edu

[PDF][PDF] Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson, M Angenendt… - British Journal of …, 2010 - Citeseer
BACKGROUND: The purpose of this work was to determine the efficacy of inhibiting
mammalian target of rapamycin (mTOR) in pancreatic cancer preclinical models and …
[HTML] nih.gov

[HTML][HTML] Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson… - British Journal of …, 2010 - ncbi.nlm.nih.gov
Background: The purpose of this work was to determine the efficacy of inhibiting mammalian
target of rapamycin (mTOR) in pancreatic cancer preclinical models and translate preclinical …

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson… - British journal of …, 2010 - mayoclinic.elsevierpure.com
Background: The purpose of this work was to determine the efficacy of inhibiting mammalian
target of rapamycin (mTOR) in pancreatic cancer preclinical models and translate preclinical …
[PDF] researchgate.net

[PDF][PDF] Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson… - British Journal of …, 2010 - researchgate.net
BACKGROUND: The purpose of this work was to determine the efficacy of inhibiting
mammalian target of rapamycin (mTOR) in pancreatic cancer preclinical models and …
[PDF] academia.edu

[PDF][PDF] Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson… - British Journal of …, 2010 - academia.edu
BACKGROUND: The purpose of this work was to determine the efficacy of inhibiting
mammalian target of rapamycin (mTOR) in pancreatic cancer preclinical models and …

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I Garrido-Laguna, AC Tan, M Uson… - British Journal of …, 2010 - pure.korea.ac.kr
Background: The purpose of this work was to determine the efficacy of inhibiting mammalian
target of rapamycin (mTOR) in pancreatic cancer preclinical models and translate preclinical …

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.

I Garrido-Laguna, AC Tan, M Uson… - British Journal of …, 2010 - europepmc.org
Background The purpose of this work was to determine the efficacy of inhibiting mammalian
target of rapamycin (mTOR) in pancreatic cancer preclinical models and translate preclinical …

[引用][C] Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer

I GARRIDO-LAGUNA, AC TAN… - British journal of …, 2010 - pascal-francis.inist.fr
Author GARRIDO-LAGUNA, I 1; TAN, A. C 1; LACOBUZIO-DONAHUE, C 1; BARRETT, M 2;
RUDEK, M. A 1; RUBIO-VIQUEIRA, B 3 4 5; LAHERU, D 1; HIDALGO, M 3 4 5; USON, M 1; …